{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"2.410","rs_stock_flag":false,"fiscal_year_end":"31 Dec 2024","hist_closedate":"25 Sep 2025","replication_method":null,"amt_os":"588,835,343","primaryexch":"HKEX","ric":"0950.HK","product_subtype":null,"db_updatetime":"26 Sep 2025 18:38","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":0.1581,"inline_upper_strike_price":"","sedol":"BQZF1T7","am":"8.61","iv":"","ew_strike":"","as":"2.310","geographic_focus":null,"incorpin":"Cayman Islands","etp_baseCur":null,"ew_amt_os":"","bd":"2.300","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"500","update_time":"2025-09-26 10:38:37.0","lo52":"1.120","shares_issued_date":"31 Aug 2025","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Lee Siu Fong","underlying_ric":"0950.HK","hi52":"2.700","issuer_name":"Lee's Pharmaceutical Holdings Ltd.","h_share_flag":false,"ew_sub_per_from":"","div_yield":"2.04","interest_payment_date":"-","updatetime":"26 Sep 2025 16:08","aum_date":"","lo":"2.280","mkt_cap":"1.35","f_aum_hkd":null,"ew_sub_per_to":"","ls":"2.300","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0.000","aum":"","issued_shares_class_B":null,"vo":"3.68","secondary_listing_flag":false,"listing_date":"15 Jul 2002","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Lee's Pharmaceutical Holdings Ltd.","nm_s":"LEE'S PHARM","sym":"950","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.010","strike_price":"","summary":"Lee's Pharmaceutical Holdings Ltd is an investment holding company principally engaged in the development, manufacturing, marketing and sales of pharmaceutical products. The Company operates its business through two segments. The Imported Products segment is engaged in the sale of imported products. Its imported products include Keyan injection, Fipril oral solution and others. The Proprietary Products segment is engaged in the manufacture and sale of self-developed products. Its R&D products include Resilicon Tablets, ADASUVE Inhalation Powder and others. The Company's medicines cover the fields of cardiovascular and infectious diseases, dermatology, oncology, gynecology and ophthalmology. The Company mainly operates its business in mainland China, Hong Kong and Taiwan.","op":"2.290","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"14/05/2010","hsic_sub_sector_classification":"Pharmaceuticals","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"1/F, Building 20E, Phase 3<br/>Hong Kong Science Park<br/>Shatin, New Territories<br/>Hong Kong","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"14.55","eps_ccy":"HKD","hdr":false,"launch_date":"","hc":"2.300","isin":"KYG5438W1116","moneyness":""}},"qid":"1758890409763"}
